Role of staphylococcal superantigens in airway disease

Chemical Immunology and Allergy

Volumn 93, Issue 1, 2007, Pages 214-236

  Bachert, Claus ^a   Gevaert, P ^a   Zhang, Nan ^a   van Zele, T ^a   Perez Novo, Claudina ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN E; STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; ENTEROTOXIN;

ADAPTIVE IMMUNITY; ALLERGIC RHINITIS; ARTICLE; ASTHMA; B LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATION ANALYSIS; DISEASE MODEL; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EOSINOPHIL; EPITHELIUM CELL; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; LOWER RESPIRATORY TRACT; LYMPHOCYTE FUNCTION; NONHUMAN; NOSE POLYP; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; RESPIRATORY TRACT DISEASE; STAPHYLOCOCCUS; T LYMPHOCYTE; TH2 CELL; UPPER RESPIRATORY TRACT; WHEEZING; ABNORMAL RESPIRATORY SOUND; ANIMAL; HAY FEVER; IMMUNOLOGY; REVIEW; STAPHYLOCOCCUS AUREUS;

ANIMALS; ASTHMA; ENTEROTOXINS; HUMANS; NASAL POLYPS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SOUNDS; RHINITIS, ALLERGIC, SEASONAL; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 34249740696     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000100897     Document Type: Article

References (64)

1. Balaban N, Rasooly A: Staphylococcal enterotoxins. Int J Food Microbiol 2000;61:1-103.
2. Yarwood JM, Mccormick JK, Schlievert PM: Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J Bacteriol 2001;183:1113-1123.
3. Jarraud S, Peyrat MA, Lim A, et al: Egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 2001;166:669-677.
4. De Marzi MC, Fernandez MM, Sundberg EJ, et al: Cloning, expression and interaction of human T-cell receptors with the bacterial superantigen SSA. Eur J Biochem 2004;271:4075-4083.
5. Sutkowski N, Chen G, Calderon G, Huber BT: Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol 2004;78:7852-7860.
6. Pobezinskaya Y, Chervonsky AV, Golovkina TV: Initial stages of mammary tumor virus infection are superantigen independent. J Immunol 2004;172:5582-5587.
7. Llewelyn M, Sriskandan S, Peakman M, et al: HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 2004;172:1719-1726.
8. Bachert C, van Zele T, Gevaert P, De Schrijver L, Van Cauwenberge P: Superantigens and nasal polyps. Curr Allergy Asthma Rep 2003;3:523-531.
9. Farthing MJH, Jeffries DJ, Anderson J: Infectious diseases, tropical medicine and sexually transmitted diseases; in Kumar PJ, Clark ML (eds): Clinical Medicine, ed 3. London, Bailliere Tindall, 1994, pp 1-105.
10. Bachert C, Gevaert P, Holtappels G, Johansson SG, Van Cauwenberge P: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614.
11. Park HS, Jung KS, Shute J, Robert K, Holgate ST, Djukanovic R: Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Respir J 1997;7:1476-1482.
12. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158: 3902-3908.
13. Conley DB, Tripathi A, Ditto AM, Reid K, Grammer LC, Kern RC: Chronic sinusitis with nasal polyps: Staphylococcal exotoxin immunoglobulin E and cellular inflammation. Am J Rhinol 2004;18:273-278.
14. Caplin I, Haynes TJ, Spahn J: Are nasal polyps an allergic phenomenon? Ann Allergy 1971;29: 631-634.
15. Tripathi A, Conley DB, Grammer LC, et al: Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis. Laryngoscope 2004;114: 1822-1826.
16. Shiomori T, Yoshida S, Miyamoto H, Makishima K: Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis. J Allergy Clin Immunol 2000;105:449-454.
17. Rossi RE, Monasterolo G: Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SEA, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol 2004;133:261-266.
18. Riechelmann H, Essig A, Deutschle T, Rau A, Rothermel B, Weschta M: Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls. Allergy 2005;60: 1418-1423.
19. Okano M, Hattori H, Yoshino T, Sugata Y, Yamamoto M, Fujiwara T, Satoskar AA, Satoskar AR, Nishizaki K: Nasal exposure to staphylococcal enterotoxin enhances the development of allergic rhinitis in mice. Clin Exp Allergy 2005;35:506-514.
20. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P: Nasal polyposis: From cytokines to growth. Am J Rhinol 2000;14:279-290.
21. Settipane GA, Chafee FH: Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol 1977;59:17-21.
22. Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SGO: IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 2003;111:1131-1132.
23. Van Zele T, Gevaert P, Watelet JB, et al: Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004;114:981-983.
24. von Eiff C, Becker K, Metze D, et al: Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: A cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis 2001;32:1643-1647.
25. Jevon M, Guo C, Ma B, et al: Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. Infect Immun 1999;67:2677-2681.
26. Kintarak S, Whawell SA, Speight PM, Packer S, Nair SP: Internalization of Staphylococcus aureus by human keratinocytes. Infect Immun 2004;72:5668-5675.
27. da Silva MC, Zahm JM, Gras D, et al: Dynamic interaction between airway epithelial cells and Staphylococcus aureus. Am J Physiol Lung Cell Mol Physiol 2004;287:L543-L551.
28. Dziewanowska K, Carson AR, Patti JM, Deobald CF, Bayles KW, Bohach GA: Staphylococcal fibronectin binding protein interacts with heat shock protein 60 and integrins: Role in internalization by epithelial cells. Infect Immun 2000;68:6321-6328.
29. Fowler T, Wann ER, Joh D, Johansson S, Foster TJ, Hook M: Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol 2000;79:672-679.
30. Krut O, Sommer H, Kronke M: Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. J Antimicrob Chemother 2004;53:167-173.
31. Claeys S, Van Hoecke H, Holtappels G, et al: Nasal polyps in patients with and without cystic fibrosis: A differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005;35:467-472.
32. Ong PY, Ohtake T, Brandt C, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
33. Claeys S, De Belder T, Holtappels G, et al: Macrophage mannose receptor in chronic sinus disease. Allergy 2004;59:606-612.
34. 1 defines a subgroup of patients with atopic dermatitis. Clin Exp Allergy 2005;35:274-281.
35. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C: Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005;60:71-79.
36. Jabara HH, Geha RS: The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching. Int Immunol 1996;8:1503-1510.
37. Tumang JR, Zhou JL, Gietl D, Crow MK, Elkon KB, Friedman SM: T helper cell-dependent, microbial superantigen-mediated B cell activation in vivo. Autoimmunity 1996;24:247-255.
38. Hofer MF, Harbeck RJ, Schlievert PM, Leung DY: Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999;112:171-176.
39. Ying S, Humbert M, Meng Q, et al: Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol 2001;107:686-692.
40. Kleinjan A, Vinke JG, Severijnen LW, Fokkens WJ: Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000;15:491-497.
41. Coker HA, Durham SR, Gould HJ: Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 2003;171:5602-5610.
42. Smurthwaite L, Walker SN, Wilson DR, et al: Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol 2001;31:3422-3431.
43. Zollner TM, Wichelhaus TA, Hartung A, et al: Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000;30:994-1000.
44. Coker HA, Harries HE, Banfield GK, Carr VA, Durham SR, Chevretton E, et al: Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis. J Allergy Clin Immunol 2005;116:445-452.
45. Bernasconi NL, Traggiai E, Lanzavecchia A: Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298:2199-2202.
46. Traggiai E, Puzone R, Lanzavecchia A: Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003;21(suppl 2):S35-S37.
47. Perez-Novo CA, Kowalski ML, Kuna P, et al: Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: Studies on the relationship. Int Arch Allergy Immunol 2004;133:255-260.
48. Suh YJ, Yoon SH, Sampson AP, et al: Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma. Clin Exp Allergy 2004;34:1270-1275.
49. Perez-Novo CA, Watelet JB, Claeys C, van Cauwenberge P, Bachert C: Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:1189-1196.
50. Perez-Novo CA, Claeys C, Van Zele T, Holtapples G, Van Cauwenberge P, Bachert C: Eicosanoid metabolism and eosinophilic inflammation in nasal polyp patients with immune response to Staphylococcus aureus enterotoxins. Am J Rhinology 2006;20:456-460.
51. Hauk PJ, Wenzel SE, Trumble AE, Szefler SJ, Leung DY: Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: A potential role for microbial superantigens. J Allergy Clin Immunol 1999;104:37-45.
52. Herz U, Ruckert R, Wollenhaupt K, et al: Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness - a model for non-allergic asthma. Eur J Immunol 1999;29:1021-1031.
53. Hellings PW, Hens G, Meyts I, Bullens D, Vanoirbeek J, Gevaert P, Jorissen M, Ceuppens JL, Bachert C: Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B. Clin Exp Allergy 2006;36:1063-1071.
54. Hellings PW, Hessel EM, Van den Oord J, Kasran A, Van Hecke P, Ceuppens JL: Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyperreactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy 2001;31:782-790.
55. Hellings PW, Vandenberghe P, Kasran A, Coorevits L, Overbergh L, Mathieu C, Ceuppens JL: Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol 2002;32:585-594.
56. Howarth PH, Jones M, Lau L, Gevaert P, Zhang N, Johannson SGO, van Zele T, Bachert C: Specific IgE against Staphylococcus aureus enterotoxins: Relevance to asthma, asthma severity, asthma phenotype and inflammatory markers. Submitted.
57. Rohde G, Gevaert P, Holtappels G, et al: Increased IgE-antibodies to Staphylococcus aureus enterotoxins in patients with COPD. Respir Med 2004;98:858-864.
58. Heaton T, Mallon D, Venaille T, Holt P: Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: The hygiene hypothesis in reverse? Allergy 2003;58:252-256.
59. Semic-Jusufagic A, Bachert C, Gevaert P, Holtappels G, Lowe L, Woodcock A, Simpson A, Custovic A: Impact of Staphylococcus aureus sensitization on allergic diseases in early children: A population-based birth cohort study. J Allergy Clin Immunol 2007; in press.
60. Custovic A, Simpson BM, Murray CS, Lowe L, Woodcock A: The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy Immunol 2002;13(suppl 15):32-37.
61. Lowe L, Murray CS, Custovic A, Simpson BM, Kissen PM, Woodcock A: Specific airway resistance in 3-year-old children: A prospective cohort study. Lancet 2002;359:1904-1908.
62. Hauk PJ, Hamid QA, Chrousos GP, Leung DY: Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000;105:782-787.
63. Breuer K, Häussler S, Kapp A, Werfel T: Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002;147:55-61.
64. Gevaert P, Lang-Loidolt D, Stammberger H, Lackner A, Sacks H, Van Zele T, Holtappels G, Tavernier J, van Cauwenberge P, Bachert C: Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006;118:1133-1141.